ADVERTISEMENT

Billion-dollar drugs’ makers set to face their first US price negotiations


#USA#BreakingNews#News



Some of the most widely used drugs in the U.S. may be heading for lower prices under Medicare. (Dreamstime/TNS)

Some of the most widely used drugs in the U.S. may be heading for lower prices under Medicare, a move that could save taxpayers billions of dollars and squeeze profits for big pharmaceutical companies.


Originally published at Tribune News Service
Tags

Post a Comment

0Comments
Post a Comment (0)
ADVERTISEMENT
ADVERTISEMENT

#buttons=(Accept !) #days=(20)

Our website uses cookies to enhance your experience. Learn More
Accept !